The ADC targets CD22 on B cells, is internalized, and releases calicheamicin, which then binds the DNA minor groove to cause double‑strand breaks and apoptosis. The DNA minor groove is the payload binding site, not the targeting antigen, so its presence alone does not lead to killing.